In-vessel implantable smart sensing device for personalised medicine
The IV-Lab project develops a miniaturized implantable sensor for continuous health monitoring in cardiovascular patients, enabling personalized medical interventions and reducing hospitalizations.
Projectdetails
Introduction
The IV-Lab project aims at designing and manufacturing a miniaturized sensing device implantable in the blood vessel for monitoring the health status of patients. The micro-sensor system would implement a body-embedded system with multiple sensing capabilities, targeting hemodynamic and biochemical parameters, once implanted into blood vessels (vein and/or arterial blood vessels) of vulnerable patients with cardiovascular diseases.
Objectives
The final goal of the proposal aims at responding to the main requests from the Pathfinder Health work program, which is to endow people with unperceivable sensors. This will allow:
- The continuous long-term monitoring of the health status.
- The diagnosis and personalized medical intervention.
Device Functionality
Once in the vessel, the sensor will be completely unobtrusive and capable of continuous monitoring. The implanted system will be connected with (and powered by) an external data collection and communication system coupled through standardized wireless technology (i.e., NFC), or even simply by a smartphone in case of asynchronous on-demand monitoring.
Design Features
The device will have miniaturized and shaped size allowing placement inside veins and arteries without impairing blood flow. It will be provided with multiple different sensors, able to work in a continuous or asynchronous way, depending on the specific use cases.
Applications
This device will find important applications in the field of cardiovascular disease, particularly in those patients in which the detection of hemodynamic behavior and specific biomarkers could reduce re-hospitalization and mortality (i.e., heart failure).
Future Perspectives
Moreover, in perspective, the system will make it possible to monitor the development and outcome of different diseases, allowing for prompt and tailored treatment.
Financiële details & Tijdlijn
Financiële details
Subsidiebedrag | € 4.158.610 |
Totale projectbegroting | € 4.158.610 |
Tijdlijn
Startdatum | 1-9-2023 |
Einddatum | 31-8-2027 |
Subsidiejaar | 2023 |
Partners & Locaties
Projectpartners
- FONDAZIONE ISTITUTO ITALIANO DI TECNOLOGIApenvoerder
- CONSIGLIO NAZIONALE DELLE RICERCHE
- THE PROVOST, FELLOWS, FOUNDATION SCHOLARS & THE OTHER MEMBERS OF BOARD, OF THE COLLEGE OF THE HOLY & UNDIVIDED TRINITY OF QUEEN ELIZABETH NEAR DUBLIN
- FUNDACIO INSTITUT DE BIOENGINYERIA DE CATALUNYA
- UNIVERSITY OF STUTTGART
Land(en)
Vergelijkbare projecten binnen EIC Pathfinder
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
A multiplexed biomimetic imaging platform for assessing single cell plasticity (Plastomics) and scoring of tumour malignancyThe PLAST_CELL project aims to develop a microfluidics-based imaging platform to quantify cancer cell plasticity, enhancing diagnosis and treatment of metastasis and therapy resistance. | EIC Pathfinder | € 2.982.792 | 2022 | Details |
"Creation of innovative ""humidity to electricity"" renewable energy conversion technology towards sustainable energy challenge"The CATCHER project aims to develop scalable technology for converting atmospheric humidity into renewable electricity, enhancing EU leadership in clean energy innovation. | EIC Pathfinder | € 2.996.550 | 2022 | Details |
Smart Electronic Olfaction for Body Odor DiagnosticsSMELLODI aims to digitize and synthesize olfactory information for remote disease diagnostics and assist individuals with olfactory disorders using advanced sensor technology and machine learning. | EIC Pathfinder | € 3.263.781 | 2022 | Details |
Quantitative Ultrasound Stochastic Tomography - Revolutionizing breast cancer diagnosis and screening with supercomputing-based radiation-free imaging.The project aims to revolutionize breast cancer imaging by developing adjoint-based algorithms for uncertainty quantification, enhancing diagnostic confidence through high-resolution, radiation-free images. | EIC Pathfinder | € 2.744.300 | 2022 | Details |
A multiplexed biomimetic imaging platform for assessing single cell plasticity (Plastomics) and scoring of tumour malignancy
The PLAST_CELL project aims to develop a microfluidics-based imaging platform to quantify cancer cell plasticity, enhancing diagnosis and treatment of metastasis and therapy resistance.
"Creation of innovative ""humidity to electricity"" renewable energy conversion technology towards sustainable energy challenge"
The CATCHER project aims to develop scalable technology for converting atmospheric humidity into renewable electricity, enhancing EU leadership in clean energy innovation.
Smart Electronic Olfaction for Body Odor Diagnostics
SMELLODI aims to digitize and synthesize olfactory information for remote disease diagnostics and assist individuals with olfactory disorders using advanced sensor technology and machine learning.
Quantitative Ultrasound Stochastic Tomography - Revolutionizing breast cancer diagnosis and screening with supercomputing-based radiation-free imaging.
The project aims to revolutionize breast cancer imaging by developing adjoint-based algorithms for uncertainty quantification, enhancing diagnostic confidence through high-resolution, radiation-free images.
Vergelijkbare projecten uit andere regelingen
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Implantable sensors and ultrasonic data link with triggered bioresorption for next-gen wireless cardiac monitoringThe 2ND-CHANCE project aims to develop bioresorbable implants for continuous cardiac monitoring post-surgery, reducing rehospitalization risks and eliminating the need for removal surgery. | ERC STG | € 2.500.000 | 2022 | Details |
Novel microsensing platform for remote patient monitoringThe FORESEE project aims to advance implantable microstimulators for remote monitoring of chronic heart failure, enhancing patient care and market access for 10.5 million potential users. | EIC Transition | € 2.499.051 | 2023 | Details |
Clinical validation of the First Implantable Sensor System for Wireless detection of stent occlusion/ restenosisVesselSens is developing StentGuard, a smart device for early, non-invasive detection of restenosis in PAD patients to improve outcomes and reduce healthcare costs. | EIC Accelerator | € 2.500.000 | 2022 | Details |
SmartIVHet project onderzoekt de haalbaarheid van een bio-geïnspireerd inline infuusmonitoringsysteem om de veiligheid van IV-infusen te verbeteren door nauwkeurige flowmeting en commerciële strategieën te evalueren. | MIT Haalbaarheid | € 19.983 | 2022 | Details |
Implantable sensors and ultrasonic data link with triggered bioresorption for next-gen wireless cardiac monitoring
The 2ND-CHANCE project aims to develop bioresorbable implants for continuous cardiac monitoring post-surgery, reducing rehospitalization risks and eliminating the need for removal surgery.
Novel microsensing platform for remote patient monitoring
The FORESEE project aims to advance implantable microstimulators for remote monitoring of chronic heart failure, enhancing patient care and market access for 10.5 million potential users.
Clinical validation of the First Implantable Sensor System for Wireless detection of stent occlusion/ restenosis
VesselSens is developing StentGuard, a smart device for early, non-invasive detection of restenosis in PAD patients to improve outcomes and reduce healthcare costs.
SmartIV
Het project onderzoekt de haalbaarheid van een bio-geïnspireerd inline infuusmonitoringsysteem om de veiligheid van IV-infusen te verbeteren door nauwkeurige flowmeting en commerciële strategieën te evalueren.